068760.KQ
Celltrion Pharm, Inc.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 40,850.00
−0.73%Margins
Gross margin
30.1%
EBITDA margin
14.9%
EBIT margin
10.7%
Net margin
7.4%
FCF margin
6.4%
9.5%
Return on equity
5.5%
Return on assets
10.2%
Return on invested capital
0.75x
Asset turnover
KRW 61.4B
Cash from operations
KRW 2.8K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026